Dementia prevention, intervention, and care: 2024 report of the
WEBJul 31, 2024 · The 2024 update of the Lancet Commission on dementia provides new hopeful evidence about dementia prevention, intervention, and care.
Lecanemab in Early Alzheimer’s Disease | New England Journal of …
WEBNov 29, 2022 · We conducted an 18-month, multicenter, double-blind, phase 3 trial involving persons 50 to 90 years of age with early Alzheimer’s disease (mild cognitive impairment or mild dementia due to ...
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Alzheimer’s study finds diet, lifestyle changes yield improvements
WEBJul 8, 2024 · Tantalizing new research suggests intensive diet and lifestyle changes may not only forestall cognitive decline related to Alzheimer’s disease but possibly bring some improvement to those in early stages. The small, limited study varied from earlier findings, which concluded a healthy lifestyle could lower risk but showed little promise in ...
Silent brain changes precede Alzheimer’s. Researchers have new …
WEBFeb 21, 2024 · WASHINGTON (AP) — Alzheimer’s quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes — a potential window to one day intervene.
Lecanemab, the New Alzheimer’s Treatment: 3 Things To Know
WEBJul 24, 2023 · The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
First-of-its-kind test can predict dementia up to nine years before ...
WEBJun 6, 2024 · Dec. 16, 2021 — Artificial intelligence can predict which people who attend memory clinics will develop dementia within two years with 92 per cent accuracy, a largescale new study has...
Alzheimer’s drug donanemab: what promising trial means for
WEBMay 4, 2023 · On 3 May, pharmaceutical company Eli Lilly announced in a press release that its monoclonal antibody donanemab slowed mental decline by 35% for some participants in a 1,736-person trial — a rate...
Researchers call for a major rethink of how Alzheimer’s ... - Nature
WEBMar 13, 2024 · In January 2023, the US Food and Drug Administration (FDA) approved lecanemab — an antibody medication that decreases β-amyloid protein build-up in the brain — as a treatment for Alzheimer’s...